NEWS
Home / News
Mission Bio Names Stuart Essig Chair of its Board of Directors
SOUTH SAN FRANCISCO, Calif., March 17, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced it has appointed Stuart Essig, PhD, as Chair of its Board of Directors. Dr. Essig is currently a...
OLSF Ventures leads $4.5 million investment in Broken Arrow-based Access Optics
Tulsa-based Oklahoma Life Science Fund Ventures (OLSF) recently led a $4.5 million Series A Preferred investment in Access Optics, a Broken Arrow-based global manufacturing leader of micro-scale surgical imaging products. Joining OLSF in the investment was Plains...
Gilmartin Capital Launches Inaugural Fund
Venture fund founded by leading medical technology analyst David Lewis Gilmartin Capital to focus on investments in medical devices, life science tools, diagnostics, and digital health SAN FRANCISCO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Gilmartin Capital, LLC,...
SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results
Download PDF Provides 2022 Revenue Guidance CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today...
Breg Announces New President and CEO
Orthopedic Company Recruits Global Medical Technology Leader to Advance Next Phase of Expansion CARLSBAD, Calif., March 14, 2022 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, announced today that its board of directors has...
Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors
NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq: BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders,...
Broken Arrow surgical device company draws investment
BROKEN ARROW – Access Optics, which is focused on developing and manufacturing “microscale” surgical devices, has recently drawn millions of dollars in new investment. OLSF Ventures recently led a $4.5 million Series A Preferred investment in the Broken Arrow company,...
EVERSANA and Intouch Group Join Forces
Chicago and Kansas City, Mo. — EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, and Intouch Group, a full-service global agency network serving the pharmaceutical industry, today announced that they signed an agreement...
EVERSANA Completes Acquisition of Intouch Group
Chicago and Kansas City, Mo. — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today announced it has completed its acquisition of Intouch Group®, a full-service global agency network serving the pharmaceutical...